PCM
BPMC
Prelude Capital Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.71M | Buy |
+60,154
| New | +$7.71M | 0.75% | 16 |
|
|
2025
Q1 | – | Sell |
-8,552
| Closed | -$746K | – | 1112 |
|
|
2024
Q4 | $746K | Sell |
8,552
-1,668
| -16% | -$145K | 0.05% | 385 |
|
|
2024
Q3 | $945K | Buy |
+10,220
| New | +$945K | 0.06% | 347 |
|
|
2022
Q1 | – | Sell |
-8,950
| Closed | -$959K | – | 1542 |
|
|
2021
Q4 | $959K | Sell |
8,950
-1
| -0% | -$107 | 0.02% | 484 |
|
|
2021
Q3 | $920K | Buy |
8,951
+1,001
| +13% | +$103K | 0.02% | 437 |
|
|
2021
Q2 | $699K | Buy |
+7,950
| New | +$699K | 0.02% | 614 |
|
|
2020
Q4 | – | Sell |
-950
| Closed | -$88K | – | 858 |
|
|
2020
Q3 | $88K | Buy |
+950
| New | +$88K | ﹤0.01% | 721 |
|
|
2020
Q1 | – | Sell |
-7,500
| Closed | -$601K | – | 992 |
|
|
2019
Q4 | $601K | Buy |
+7,500
| New | +$601K | 0.02% | 285 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1204 |
|
|
2018
Q4 | – | Sell |
-9,172
| Closed | -$716K | – | 1406 |
|
|
2018
Q3 | $716K | Buy |
9,172
+5,593
| +156% | +$437K | 0.04% | 280 |
|
|
2018
Q2 | $227K | Buy |
+3,579
| New | +$227K | 0.01% | 569 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1351 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1235 |
|
|
2017
Q3 | – | Sell |
-235
| Closed | -$12K | – | 1493 |
|
|
2017
Q2 | $12K | Buy |
+235
| New | +$12K | ﹤0.01% | 1241 |
|